An Open Label Study in Adults with Atopic Dermatitis to Assess Variability in Immune Response to Fluzone Intradermal Vaccine

Trial Location:
Main Campus, Denver, CO
Principal Investigator:

Mark Boguniewicz MD
Donald Y.M. Leung MD, PhD

Trial Sponsor(s):

NIH - DAIT

Trial Objective:

The purpose of this study is to determine the difference in variability to response to influenza vaccine between participants with atopic dermatitis and healthy controls.

Study involves 1 possibly 2-3 visits.

Compensation:

Provided

Who Can Participate:

Qualifications include males and females ages 18-55 with Atopic Dermatitis and healthy controls.

Enrollment:

Active Clinical Trials Currently Recruiting

How to Participate:

For more information, please call Trish Taylor, NP at 303.398.1067 or CTRC at 303.398.1409.

Bookmark and Share